Phenyl N-(2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)carbamate

Catalog No. :
ACXIEP728
CAS No. :
949835-58-9
Molecular Formula :
C16H12N2O4
Molecular Weight :
296.28

IUPAC Name:phenyl (2-methyl-1,3-dioxoisoindolin-5-yl)carbamate

Phenyl N-(2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$205.00Login to see priceInquiryInquiry
5g95%$597.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePhenyl N-(2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)carbamate
IUPAC Namephenyl (2-methyl-1,3-dioxoisoindolin-5-yl)carbamate
MDL No.MFCD09802109
Molecular FormulaC16H12N2O4
Molecular Weight296.28
SMILESO=C(OC1=CC=CC=C1)NC2=CC3=C(C(N(C)C3=O)=O)C=C2
InChI KeyHNQCDEGGCXUUHJ-UHFFFAOYSA-N
SynonymCarbamic acid, N-(2,3-dihydro-2-methyl-1,3-dioxo-1H-isoindol-5-yl)-, phenyl ester;Phenyl (2-methyl-1,3-dioxoisoindolin-5-yl)carbamate
CAS No.949835-58-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXIEP728 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJMDH279 route compound structure diagram
    ACJMDH2792307-00-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXIEP728 route product structure diagram
    ACXIEP728949835-58-9
Inquiry

2. ACXIEP728 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJMDH279 route compound structure diagram
    ACJMDH2792307-00-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXIEP728 route product structure diagram
    ACXIEP728949835-58-9
Inquiry

Comments (0)